Enanta Pharmaceuticals
ENTA
#8720
Rank
โ‚ฌ0.20 B
Marketcap
6,94ย โ‚ฌ
Share price
-4.51%
Change (1 day)
-33.93%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of November 2026 (TTM): 3.41

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.20. At the end of 2026 the company had a P/S ratio of 6.24.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20266.240.39%
20256.21224.85%
20241.91-28.93%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59 93.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.00 46.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
7.74 126.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
10.2 199.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.93 44.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.42-29.22%๐Ÿ‡บ๐Ÿ‡ธ USA